[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group].

Background: Biologic therapies have been a major breakthrough in the treatment of psoriasis because they are more selective and have a better short-term and medium- term safety profile. There are reliable data to support both the efficacy and the safety of these drugs. However, it is always useful to report the clinical experience of dermatologists who are experts in the use of biologic agents to treat psoriasis, particularly with regard to their safety. Material and methods: We present the results of a survey administered to the members of Spanish Psoriasis Group and based on a series of questions referring to the clinical